ASHLEY HEALY: Open Payments
NPI 1194230706 · FLEMINGSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 47 payments from 14 companies in 2025. Trend: 2023 $1,181 · 2024 $1,462 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $244 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Novo Nordisk Inc | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: UBRELVY, FARXIGA, REXULTI, Auvelity, Ozempic, QULIPTA, GEMTESA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
